Latest News

Shares of Australian biotech major CSL plunge 17% after CEO departure, weak earnings

February 10, 2026 at 11:29 PM
By CNBC

Advertisement Space - Below Article Title

Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down with immediate effect.

Analysis & Context

Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down with immediate effect. Shares of Australian biotech major CSL plunge 17% after CEO departure, weak earnings. Stay informed with the latest developments and expert analysis on this important story.

Advertisement Space - In-Article Ad

Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down with immediate effect.

Advertisement Space - End of Article

Related Articles